Covaxin update: Bharat Biotech gets nod from DCGI panel for Phase III trials2 min read . Updated: 22 Oct 2020, 09:49 PM IST
- The panel added that the recommendation is after assessing data from Phase I & II as well as animal challenge study
- Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the DCGI
Drugs Controller General of India (DCGI's) Subject Expert Committee (SEC) recommended granting of permission to conduct Phase III clinical trials for Bharat Biotech's Covid-19 vaccine Covaxin.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more